Esslinger CS[au] - Search Results

Year	Number of Results
1998	2
1999	2
2002	1
2005	3
2007	1
2008	1
2022	0

1

The excitatory amino acid transporters: pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes.

Bridges RJ, Esslinger CS. Bridges RJ, et al. Among authors: esslinger cs. Pharmacol Ther. 2005 Sep;107(3):271-85. doi: 10.1016/j.pharmthera.2005.01.002. Epub 2005 Apr 14. Pharmacol Ther. 2005. PMID: 16112332 Review.

2

Ngamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site.

Esslinger CS, Cybulski KA, Rhoderick JF. Esslinger CS, et al. Bioorg Med Chem. 2005 Feb 15;13(4):1111-8. doi: 10.1016/j.bmc.2004.11.028. Bioorg Med Chem. 2005. PMID: 15670919

3

The substituted aspartate analogue L-beta-threo-benzyl-aspartate preferentially inhibits the neuronal excitatory amino acid transporter EAAT3.

Esslinger CS, Agarwal S, Gerdes J, Wilson PA, Davis ES, Awes AN, O'Brien E, Mavencamp T, Koch HP, Poulsen DJ, Rhoderick JF, Chamberlin AR, Kavanaugh MP, Bridges RJ. Esslinger CS, et al. Neuropharmacology. 2005 Nov;49(6):850-61. doi: 10.1016/j.neuropharm.2005.08.009. Epub 2005 Sep 23. Neuropharmacology. 2005. PMID: 16183084

4

Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles.

Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ. Bartlett RD, et al. Among authors: esslinger cs. Neuropharmacology. 1998 Jul;37(7):839-46. doi: 10.1016/s0028-3908(98)00080-x. Neuropharmacology. 1998. PMID: 9776380

5

Differentiation of substrate and nonsubstrate inhibitors of the high-affinity, sodium-dependent glutamate transporters.

Koch HP, Kavanaugh MP, Esslinger CS, Zerangue N, Humphrey JM, Amara SG, Chamberlin AR, Bridges RJ. Koch HP, et al. Among authors: esslinger cs. Mol Pharmacol. 1999 Dec;56(6):1095-104. doi: 10.1124/mol.56.6.1095. Mol Pharmacol. 1999. PMID: 10570036

6

Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport.

Carrigan CN, Bartlett RD, Esslinger CS, Cybulski KA, Tongcharoensirikul P, Bridges RJ, Thompson CM. Carrigan CN, et al. Among authors: esslinger cs. J Med Chem. 2002 May 23;45(11):2260-76. doi: 10.1021/jm010261z. J Med Chem. 2002. PMID: 12014964

7

Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3.

Mavencamp TL, Rhoderick JF, Bridges RJ, Esslinger CS. Mavencamp TL, et al. Among authors: esslinger cs. Bioorg Med Chem. 2008 Aug 15;16(16):7740-8. doi: 10.1016/j.bmc.2008.07.001. Epub 2008 Jul 8. Bioorg Med Chem. 2008. PMID: 18650095 Free PMC article.

8

Design, synthesis, and biological activity of novel triazole amino acids used to probe binding interactions between ligand and neutral amino acid transport protein SN1.

Gajewski M, Seaver B, Esslinger CS. Gajewski M, et al. Among authors: esslinger cs. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4163-6. doi: 10.1016/j.bmcl.2007.05.061. Epub 2007 May 23. Bioorg Med Chem Lett. 2007. PMID: 17561393 Free PMC article.

9

Structural determinants of substrates and inhibitors: probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate.

Esslinger CS, Koch HP, Kavanaugh MP, Philips DP, Chamberlin AR, Thompson CM, Bridges RJ. Esslinger CS, et al. Bioorg Med Chem Lett. 1998 Nov 3;8(21):3101-6. doi: 10.1016/s0960-894x(98)00560-5. Bioorg Med Chem Lett. 1998. PMID: 9873684

10

Quinoline-2,4-dicarboxylic acids: synthesis and evaluation as inhibitors of the glutamate vesicular transport system.

Carrigan CN, Esslinger CS, Bartlett RD, Bridges RJ, Thompson CM. Carrigan CN, et al. Among authors: esslinger cs. Bioorg Med Chem Lett. 1999 Sep 6;9(17):2607-12. doi: 10.1016/s0960-894x(99)00444-8. Bioorg Med Chem Lett. 1999. PMID: 10498218

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results